Superangel
VC Fund
Tallinn, Estonia
Superangel is an early stage fund investing into for the builders of world-changing technology in the Baltics and Nordics.Based in Tallinn, Superangel is founded, run and backed by tech entrepreneurs who know what it takes to build industry-defining companies. They're early backers of global success stories such as Bolt, Pipedrive, Grabcad,and Veriff – and have the founders they once invested in backing Superangel today.
- Total investments:
- 82
- Last investment:
- Lead investor:
- 40%
- Fund size:
- $32M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Superangel invests in
Stages Superangel invests in
Countries Superangel invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $800k–$6.2M
- Pre-Seed
- $170k–$1.6M
- Series A
- $5.6M–$20M
Investment Focus
Industry
- Artificial Intelligence 15 (18%)
- Software 13 (16%)
- Information Technology 10 (12%)
- SaaS 5 (6%)
- FinTech 4 (5%)
Stage
- Seed 31 (38%)
- Pre-Seed 21 (26%)
- Series A 8 (10%)
- Angel 3 (4%)
- Series B 2 (2%)
Country
- Estonia 25 (30%)
- United States 10 (12%)
- Finland 3 (4%)
- United Kingdom 3 (4%)
- Latvia 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Céline Pattyranie
Investment Associate
|
Investment Associate | Total investments: 2 | Find email | |
Jaan Kokk
Portfolio Administrator & Investment Associate
|
Portfolio Administrator & Investment Associate | Total investments: 1 | Find email | |
Kaari Kink
Associate
|
Associate | Total investments: 1 | Find email | |
Kalev Kaarna
Venture Development Manager
|
Venture Development Manager | Total investments: 0 | Find email | |
Marek Kiisa
Founding Partner
|
Founding Partner | Total investments: 55 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $1.8M / Venture - Series Unknown / Jun 09, 2026 | ||
| Spiral Hydrogen's mission is to lower the price of green hydrogen below that of fossil hydrogen, so opening up an industry for decarbonization and making hydrogen transportation and heating commercially viable. | $3.1M / Pre-Seed / Apr 30, 2026 | ||
| OTee specializes in the development of industrial automation software, offering a comprehensive solution for the setup, testing, and safe operation of operational facilities in real time. The company's platform is designed to provide automation engineers with a secure, scalable, and user-friendly environment. By utilizing OTee's software,businesses can streamline their operations, allowing them to concentrate on their core tasks while enhancing the performance of their facilities. | $6.2M / Seed / Apr 28, 2026 | ||
| Sky Spy is a dual-use technology company developing innovative, compact, and reliable SIGINT systems for contested electromagnetic environments. Built through direct feedback from active combat zones, our products are designed alongside frontline military operators to ensure real-world effectiveness.Headquartered across the U.S. and the EU, weoperate as an agile, multinational team of veterans and technologists, committed to supporting NATO and allied forces with field-tested innovation.Our long-term vision is to become the global leader in multi-domain signal intelligence - delivering trusted RF awareness across air, ground, sea, and space, and empowering users with tools designed where they are needed most. | $1.6M / Pre-Seed / Nov 30, 2025 | ||
| Project Q is an ultra-fast, super accurate qualification tool to capture customer needs. | $8.7M / Seed / Jul 28, 2025 | ||
| Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees. | $23M / Series B / Jul 24, 2025 | ||
| We are a team of veterans, humanitarians, software engineers, cloud infrastructure and blockchain specialists unified by a single mission: To help our clients in the public and private sector optimise how they can manage globally distributed networks of people and teamsWe help clients in the private and public sectors eliminate the frictionsassociated with remotely managing global networks of people and communities. To do this, we are building the world's first unified, secure and integrated platform for scaling team and programme management at reach. At Labrys we deliver two types of services for our customers in the public and private sector:• A Software-as-a-Service (SaaS) offering, where our clients take our software and manage their own global teams and programmes• A Managed Service, where we use our software and unique global access to manage client requirements and programmes | $20M / Series A / Jun 03, 2025 | ||
| Askel.ai elevates SaaS with embedded AI automation. | $401.5K / Pre-Seed / Dec 08, 2024 | ||
| Pactum is an AI platform that automates commercial negotiations for businesses, allowing sales teams to engage in personalized discussions with suppliers. The platform streamlines the negotiation process, enabling companies to optimize contract terms and improve procurement efficiency. By leveraging advanced algorithms, Pactum analyzes data tosupport informed decision-making during negotiations. This approach helps organizations manage multiple supplier relationships effectively while reducing the time and resources spent on negotiations. Pactum's technology empowers sales development representatives to focus on strategic initiatives rather than administrative tasks, enhancing overall productivity within sales teams. | $20M / Series B / Jul 11, 2024 | ||
| Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $1.9M / Venture - Series Unknown / May 16, 2024 | ||
| See all 82 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Superangel invest in?
Superangel invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 82 investments tracked by Shizune back companies in Estonia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Superangel's check size?
Superangel typically joins rounds of $800k–$6.2M at Seed, $170k–$1.6M at Pre-Seed and $5.6M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Superangel participates in.
How do I contact Superangel?
Public channels for Superangel include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Superangel?
The team at Superangel includes Céline Pattyranie (Investment Associate), Jaan Kokk (Portfolio Administrator & Investment Associate) and Kaari Kink (Associate), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
